Injectable, self-gelling, biodegradable, and immunomodulatory DNA hydrogel for antigen delivery.

DNA nanotechnology-based nanosystems and macrosystems have attracted much attention in the biomedical research field. The nature of DNA endows these systems with biodegradable, biocompatible, and immunomodulatory properties. Here, we present an injectable hydrogel system that consists only of chemically synthesized short DNA strands, water, and salts. Several preparations of polypod-like structured DNA, or polypodna, were designed, including tri-, tetra-, penta- and hexapodna, as the building blocks of self-gelling DNA hydrogel. Under physiological conditions, properly designed polypodna preparations formed a hydrogel. The analysis of the modulus data of the hydrogel consisting of two sets of hexapodna preparations showed that this injectable hydrogel was reorganized at a time scale of 0.25s. Then, DNA hydrogel containing unmethylated cytosine-phosphate-guanine (CpG) dinucleotides was used to stimulate innate immunity through Toll-like receptor 9, the receptor for CpG DNA. Gel formation significantly increased the activity of immunostimulatory CpG DNA, retarded the clearance after intradermal injection into mice, and increased the immune responses to ovalbumin (OVA) incorporated into the hydrogel as a model antigen. OVA/CpG DNA hydrogel induced much less local or systemic adverse reactions than OVA injected with complete Freund's adjuvant or alum. GpC DNA hydrogel containing no CpG sequences was less effective, indicating the importance of immunomodulation by CpG DNA hydrogel. Thus, we have created an efficient system for sustained delivery of antigens or other bioactive compounds.

[1]  Dan Luo,et al.  Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice. , 2011, Biomaterials.

[2]  M. Huggins Viscoelastic Properties of Polymers. , 1961 .

[3]  D. Luo,et al.  The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity. , 2009, Biomaterials.

[4]  Y. Takakura,et al.  Induction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Dongsheng Liu,et al.  A pH-triggered, fast-responding DNA hydrogel. , 2009, Angewandte Chemie.

[6]  D. Klinman Immunotherapeutic uses of CpG oligodeoxynucleotides , 2004, Nature Reviews Immunology.

[7]  P. Rothemund Folding DNA to create nanoscale shapes and patterns , 2006, Nature.

[8]  Hao Yan,et al.  Challenges and opportunities for structural DNA nanotechnology. , 2011, Nature nanotechnology.

[9]  Y. Takakura,et al.  Injection site‐dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination , 2010, The journal of gene medicine.

[10]  M. Hashida,et al.  Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. , 2001, The Journal of pharmacology and experimental therapeutics.

[11]  Allan S Hoffman,et al.  Hydrogels for biomedical applications. , 2002, Advanced drug delivery reviews.

[12]  R. Larson The Structure and Rheology of Complex Fluids , 1998 .

[13]  Soong Ho Um,et al.  Dendrimer-like DNA-based fluorescence nanobarcodes , 2006, Nature Protocols.

[14]  장윤희,et al.  Y. , 2003, Industrial and Labor Relations Terms.

[15]  Soong Ho Um,et al.  Enzyme-catalysed assembly of DNA hydrogel , 2006, Nature materials.

[16]  P. McEuen,et al.  Controlled assembly of dendrimer-like DNA , 2004, Nature materials.

[17]  Antonios G Mikos,et al.  Gelatin as a delivery vehicle for the controlled release of bioactive molecules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Y. Takakura,et al.  Enhanced immunostimulatory activity of oligodeoxynucleotides by Y‐shape formation , 2008, Immunology.

[19]  N. Seeman,et al.  Synthesis from DNA of a molecule with the connectivity of a cube , 1991, Nature.

[20]  D. Luo,et al.  A mechanical metamaterial made from a DNA hydrogel. , 2012, Nature nanotechnology.

[21]  R. Purcell,et al.  Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo1 , 2000, The Journal of Immunology.

[22]  Hao Yan,et al.  A DNA nanostructure platform for directed assembly of synthetic vaccines. , 2012, Nano letters.

[23]  Tomoki Shiomi,et al.  Design and development of nanosized DNA assemblies in polypod-like structures as efficient vehicles for immunostimulatory CpG motifs to immune cells. , 2012, ACS nano.

[24]  J. Karbach,et al.  Therapeutic administration of a synthetic CpG oligodeoxynucleotide triggers formation of anti-CpG antibodies. , 2012, Cancer research.

[25]  Y. Takakura,et al.  DNA-based nano-sized systems for pharmaceutical and biomedical applications. , 2010, Advanced drug delivery reviews.

[26]  A. Krieg,et al.  Therapeutic potential of Toll-like receptor 9 activation , 2006, Nature Reviews Drug Discovery.

[27]  Tao Zhang,et al.  Self‐Assembled DNA Hydrogels with Designable Thermal and Enzymatic Responsiveness , 2011, Advanced materials.

[28]  D. Klinman,et al.  Use of CpG oligodeoxynucleotides as immune adjuvants , 2004, Immunological reviews.

[29]  Nadrian C. Seeman,et al.  An Overview of Structural DNA Nanotechnology , 2007, Molecular biotechnology.

[30]  D. Richman,et al.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.

[31]  H. Kiyono,et al.  Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. , 2010, Nature materials.

[32]  C. Mao,et al.  Hierarchical self-assembly of DNA into symmetric supramolecular polyhedra , 2008, Nature.

[33]  G. Hartmann,et al.  Accessing the therapeutic potential of immunostimulatory nucleic acids. , 2008, Current opinion in immunology.

[34]  S. Vogel,et al.  Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming , 2007, Proceedings of the National Academy of Sciences.

[35]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[36]  J. P. Shea,et al.  Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats. , 1994, The Journal of pharmacology and experimental therapeutics.

[37]  Andrew E. Parker,et al.  Targeting Toll-like receptors: emerging therapeutics? , 2010, Nature Reviews Drug Discovery.

[38]  Jae-Geun Yoon,et al.  Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases. , 2003, International immunology.